ABSTRACT
INTRODUCTION
Iron deficiency anaemia (IDA) is known to be a major public health problem in children and in women of childbearing age (1) . Textbook descriptions of iron deficiency usually list various signs and symptoms; however, the most important clinical clue is the presence of chronic fatigue (2) . Many bodily systems are affected by anaemia, including the immune system (3) , and deterioration of cell-mediated immune functions, as well as decreased levels of circulating peripheral blood T lymphocytes as a consequence of iron deficiency, has been shown in some studies (4) . Although human immunoglobulin levels are not decreased in iron deficiency (5) , animal studies have shown that the humoral response is quite altered (6) . Macrophages play an important role in nonspecific immunity and, with the contribution of polymorphonuclear leukocytes, represent a primary defence before the activation of both cell-mediated and humoral immunity. Data regarding in vivo macrophage function in iron deficiency are scarce; however, animal studies have demonstrated that such functions are impaired (7, 8) .
Macrophage migration inhibitory factor (MIF) is a proinflammatory cytokine that is primarily produced by activated macrophages, and has been revealed as an important player in the systemic inflammatory response (9) . MIF was discovered as a lymphokine that is involved in delayed hypersensitivity and various macrophage functions, including proinflammatory cytokine production, adherence and phagocytosis of macrophages, as well as induction of metalloproteinase and endogenous counterregulation of glucocorticoid activity (10) .
Monocyte chemoattractant protein-1 (MCP-1), also known as CC chemokine ligand 2, is one of the key chemokines regulating migration and infiltration of monocytes/macrophages (11), which are major sources of MCP-1 (12) . Mononuclear cells are mobilised from bone marrow and recruited to sites of inflammation by MCP-1.
The pathophysiological mechanisms whereby IDA promotes deterioration in immunity remain largely unexplained. Nevertheless, few in vivo studies have evaluated MIF and MCP-1 levels in IDA. The present study was designed to evaluate the influences of iron deficiency on serum MIF and MCP-1 levels.
MATERIALS AND METHODS

Study participants
The study was conducted in patients who were referred to the Internal Medicine Department of Namık Kemal University Medical Faculty, Tekirdag, Turkey, between April and June 2013. These individuals voluntarily participated in this study, the medical history of each was obtained and recent laboratory results were reviewed. A total of 30 patients (mean age 33.6±7.8 years, 30% male) presenting with IDA as the solitary pathology were included in the experimental group. The inclusion criteria were a haemoglobin (HGB) level of under 12.5 g/dl, a red blood cell (RBC) count of under 4x1012/l, a mean corpuscular volume (MCV) of under 80 fl, a mean corpuscular haemoglobin (MCH) of under 27 pg, a serum iron level of under 50 μg/dl, a total iron binding capacity (TIBC) of over 400 μg/dl and a serum ferritin level of under 20 μg/dl. The exclusion criteria were history of acute or chronic infection, a familial history of immunodeficiency, a history of cancer, a history of endocrinopathy, especially hypo-or hyperthyroidism, pregnancy and possible thalassaemia, according to the laboratory results A total of 30 healthy individuals (mean age 30.1±8.8 years, 27% male), based on recent routine laboratory results, were enrolled as the control group during the same period. Inclusion criteria were absence of anaemia and iron deficiency with a HGB level of 13-16 g/dl, an RBC count of 4-6x1012/l, an MCV of 80-96 fl, an MCH of 27-33 pg, a serum iron level of 50-150 μg/dl, a TIBC of 250-400 μg/ dl, and a serum ferritin level of 20-200 μg/dl. Participants in the control group had no history of chronic disease or drug consumption during the previous 6 months. The iron-deficient and control groups were comparable with respect to age and gender. The characteristics of the participants in the experimental and control groups are shown in Table 1 .Routine blood tests, including complete blood cell count (CBC),serum iron, total iron binding capacity, ferritin and liver enzymes, were conducted.
All participants provided informed written consent for the study, which was approved by the Ethics Committee of Namık Kemal University Medical Faculty.
Measurement of Serum Levels of MIF and MCP-1
After overnight fasting, blood samples were obtained to determine MIF and MCP-1. Serum samples, obtained by centrifugation, were then immediately frozen at -80 °C until further analysis of MIF and MCP-1 was conducted.
The serum levels of MIF (QuantikineHuman MIF ELISA; R&D Systems) and MCP-1 (Quantikine Human CCL2/MCP-1ELISA; R&D Systems) were specified with commercial enzyme-linked immunosorbent assay kits. MIF and MCP-1 were measured in a sandwich-assay format, using two specific and high affinity antibodies, streptavidin peroxidase conjugate and a chromogenic substrate. The minimum detectable levels of MIF and MCP-1 were 0.016ng/ ml and 1.7 pg/ml, respectively.
Biochemical tests and blood cell count
Serum iron and TIBC levels were measured using a Cobas C501 Roche biochemistry autoanalyser, and serum ferritin level was analysed using a Cobas e 6000 autoanalyser (Roche Diagnostics). CBC was determined usinga Roche Sysmex XT-2000i autoanalyser and commercial kits, also from Roche.
Statistical analysis
Statistical tests were performed with an SPSS 12.0 software package (Statistical Package for the Social Sciences, SPSS Inc., Chicago, IL).Data are expressed as mean ± standard deviation of the mean. The differences between groups were evaluated using the student t test. Values of p < 0.05 were considered significant.
RESULTS
There was no statistically significant difference in age and gender distribution between the experimental and control participants (p>0.05), as shown in Table 1 . Serum MIF and MCP-1 concentrations were lower in the IDA group than in the controls (p < 0.005 and p < 0.01, respectively) ( Table 1 ). The mean HGB, MCV, serum iron and ferritin levels were significantly lower, while the TIBC was higher, in the IDA group vs. the control group. Statistical analysis by t test showed significant differences between these two groups for these parameters (p<0.001), as shown in Table 2 .
DISCUSSION
Iron is essential for almost all living organisms and plays a role in a number of important biological processes, as well as in both pathogen virulence and host antimicrobial responses (13) . As a consequence, disturbances of iron homeostasis can alter the body's susceptibility to infectious disease. While there is evidence of an altered immune profile in iron deficiency, the exact immunoregulatory role of iron is poorly understood (14) . Iron deficiency relating to disturbances in humoral-and cell-mediated immunity have been studied extensively in both humans and animals. Although little evidence exists to suggest major humoral deficiencies (15) , impairment of cellmediated immunity has been well documented in iron deficiency; reduced neutrophil and macrophage function, with decreased myeloperoxidase activity, impaired bactericidal activity, a decrease in circulating peripheral T-lymphocytes with thymic atrophy, defective T lymphocyte-induced proliferative response, and impaired natural killer cell activity have all been demonstrated (16) (17) (18) .
It is well known that cytokines are involved in immune function, and iron deficiency is related to various alterations in serum cytokine levels. Decreased production of (24) . Genetic differences and the differences in the characteristics of the study groups may be responsible for this discrepancy. Secretion of MIF is mediated by several pathways, in one of which TNF-α induces MIF gene expression, resulting in elevated levels of circulating plasma MIF (25) . This mechanism led us to the hypothesis that decreased plasma MIF levels may be a consequence of decreased TNF-α levels, which is related to iron deficiency (26) .
With regard to MCP-1, we showed that there was a decrease in serum levels in participants with IDA as compared to the controls. Decreased MCP-1 levels were negatively correlated with serum iron, total iron binding capacity and ferritin levels. Although no previous in vivo studies regarding MCP-1 in iron deficiency have been conducted, a cell culture study has revealed that decreased intracellular iron was related to decreased MCP-1 secretion (27) . In a similar manner to MIF, decreased IL-1or TNF-α, due to the iron deficiency, may share responsibility for decreased levels of MCP-1, since MCP-1was shown to be secreted as a consequence of IL-1 or TNF-α stimuli (28).
In conclusion, iron deficiency depresses certain aspects of cell-mediated immunity and innate immunity, but the exact mechanism of iron deficiency-induced immune dysfunction and susceptibility to infection has not been well elucidated. Considering the role of MIF and MCP-1 in maintaining the normal immune response of the organism, a decrease in production of these cytokines in individuals with IDA may contribute to their immune dysfunction and susceptibility to infections.
